News und Analysen
DGAP-Adhoc: Vonovia SE resolves on c. EUR 8 billion fully underwritten capital increase with subscription rights to finance the business combination with Deutsche Wohnen SE
DGAP-Adhoc: Vonovia SE beschließt eine vollständig übernommene Bezugsrechtskapitalerhöhung in Höhe von ca. 8 Mrd. € zur Finanzierung der Akquisition der Deutsche Wohnen SE
Top-Deal: Siemens iQ500 Geschirrspüler SN63EX14VE jetzt um 13% reduziert!
Jetzt zugreifen: Siemens HE213ABS0 Backofen – Top Qualität zum Schnäppchenpreis!
Siemens SN63HX10TE Geschirrspüler – Top Technologie trifft Sparpreis
DGAP-Adhoc: Covestro AG: Covestro resolves on share buyback program with volume of approx. EUR 500 million
DGAP-Adhoc: Covestro AG: Covestro beschließt Aktienrückkaufprogramm mit Volumen von ca. EUR 500 Millionen
DGAP-Adhoc: Porsche Automobil Holding SE: Porsche Automobil Holding SE beschließt, einen möglichen Börsengang der Dr. Ing. h.c. F. Porsche AG weiter zu prüfen und grundsätzlich zu unterstützen
DGAP-Adhoc: Porsche Automobil Holding SE: Porsche Automobil Holding SE resolves to further examine and generally support a possible IPO of Dr. Ing. h.c. F. Porsche AG
DGAP-Adhoc: Porsche Automobil Holding SE: Porsche Automobil Holding SE bestätigt Gespräche bezüglich eines möglichen Börsengangs der Dr. Ing. h.c. F. Porsche AG
DGAP-Adhoc: Porsche Automobil Holding SE: Porsche Automobil Holding SE confirms talks regarding a possible IPO of Dr. Ing. h.c. F. Porsche AG
DGAP-Adhoc: Siemens Energy AG: Ad-hoc Announcement
These 7 Stocks Surged Double-Digits and Have Double-Digits to Go
Earnings reports often catalyze big moves in a stock’s price; the bigger the move, the more conviction the market shows. Catalysts for these moves include better-than-expected results, gained
3 small-cap biotechs with potential breakthroughs in 2024
There's a reason that many biotech investors prefer to stick with large-cap stocks. Investing in small-cap biotech stocks is not for risk-averse investors. Many are still clinical-stage companies
3 companies that more than doubled analyst EPS estimates
Earnings season is well underway, and the winner-and-loser separation continues to grow. Of the companies that beat consensus analyst estimates, even fewer go well beyond and exceed analyst
American Superconductor faster than a speeding bullet on EPS beat
Megawatt-scale power resiliency solutions provider American Superconductor Co. (NASDAQ: AMSC) shares surged 40% on its Q3 2023 earnings report and upside guidance. The computer and technology
APRISCO ENERGY INDUSTRIES Joins Forces with MAXIMANCE 2030 LTD and BLUEGRACE ENERGY BOLIVIA in a Cooperation Agreement for REDD+ Initiatives
BARCELONA, SPAIN / ACCESSWIRE / January 15, 2024 / APRISCO ENERGY INDUSTRIES S.L., a Spain-based company dedicated to a fair and sustainable energy transition, has joined forces with
Merck, the Dow's hottest stock, gets set to report Q4 financials
Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report.
Shares of the large cap pharmaceutical company
Are defensive sectors ready to outshine growth in 2024?
Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023.
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and
MAXIMANCE 2030 LTD Backs BlueGrace Energy Bolivia in Advancing Towards a Secure Model for Achieving UN Sustainable Development Goals (SDGs)
MAXIMANCE's endorsement boosts BLUEGRACE ENERGY BOLIVIA's global expansion, strengthening its international footprint and investment potential.
LONDON, UK / ACCESSWIRE / November 1, 2023 /
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
Developmental biomedical device company PetVivo Holdings Inc. (OTCMKTS: PETV) makes pet medical devices and therapeutics. What kind of medical devices would pets need? Pacemakers? Artificial hearts
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Big pharmaceutical stocks, including Novartis AG (NYSE: NVS), Eli Lilly & Co. (NYSE: LLY), Merck & Co. (NYSE: MRK), and Novo Nordisk A/S (NYSE: NVO) have been outperforming the broader market
Want Clean Energy? Siemens May Be Pointing To A Breakout
Shares of Siemens Aktiengesellschaft (OTCMKTS: SIEGY) showcased a massive 78% rally after 2022, full of natural growth, paired with enriched multiples on these expanding financials. Today, Siemens
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction. It